Search This Blog

Wednesday, August 10, 2016

Lilly Provides Update on MONARCH 2 Phase 3 Trial of Abemaciclib (NYSE:LLY)

Lilly Provides Update on MONARCH 2 Phase 3 Trial of Abemaciclib (NYSE:LLY)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.